Zobrazeno 1 - 5
of 5
pro vyhledávání: '"James E. Clune"'
Autor:
Alexander J. Kammien, BS, Neil Parikh, BS, K. Lynn Zhao, MD, James E. Clune, MD, Jonathan N. Grauer, MD, David L. Colen, MD
Publikováno v:
Plastic and Reconstructive Surgery, Global Open, Vol 12, Iss S4, Pp 56-57 (2024)
Externí odkaz:
https://doaj.org/article/7772b823bf14455c91806f6fc0ab4e7e
Autor:
Alexander E. Frey, Daniel M. Kerekes, Sajid A. Khan, Thuy T. Tran, Harriet M. Kluger, James E. Clune, Stephan Ariyan, Mario Sznol, Jeffrey J. Ishizuka, Kelly L. Olino
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundImmunotherapy agents are approved for adjuvant treatment of stage III melanoma; however, evidence for survival benefit in early stage III disease is lacking. Current guidelines for adjuvant immunotherapy utilization in stage IIIA rely on cl
Externí odkaz:
https://doaj.org/article/ddc0f0206d7a46fda9e76b144e93694b
Publikováno v:
Plastic and Reconstructive Surgery, Global Open, Vol 11, Iss 3, p e4874 (2023)
Summary:. Reconstruction of lid-cheek junction defects has a known risk of ectropion. Cervicofacial flaps require significant dissection and can still be prone to ectropion. V-Y advancement flaps have been described as less morbid, but their use is l
Externí odkaz:
https://doaj.org/article/eeb82ce6bede419c8c210b8414584fa7
Autor:
Catherine L. Ly, Ondrej Blaha, Wei Wei, Anjela Galan, Harriet Kluger, Stephan Ariyan, Kelly Olino, James E. Clune
Publikováno v:
Frontiers in Oncology, Vol 12 (2023)
BackgroundMitotic rate (MR) is considered an important prognostic factor for melanoma but is not currently used for staging because its nuanced effect is not yet well-delineated. We sought to determine if T category-specific MR is predictive of senti
Externí odkaz:
https://doaj.org/article/1eddfb766ed449e98fa45ceb9b4a948c
Autor:
Marianna V Papageorge, Renee M Maina, Amber King, Victor Lee, Raymond Baumann, Stephan Ariyan, Sajid A Khan, James E Clune, Kelly L Olino
Publikováno v:
Journal of the American College of Surgeons. 235:S257-S257